Join
Live feed
·
INSIDERFilingvia Quantisnow
Janux Therapeutics Inc. logo

Chief Technical Officer Winter Charles M. sold $32,966 worth of shares (2,401 units at $13.73) and was granted 28,600 shares, increasing direct ownership by 33% to 106,321 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JANX (Janux Therapeutics Inc.) and more on Quantisnow.